Pharmanaught

Investor, Trader, Pharmaceutical professional with a side of Crypto

[Pharmanaught @pharmanaught]

@ChartistAIM 102 closing

[Pharmanaught @pharmanaught]

@Borg74 Looking for an entry myself but cautious with a blackswan placing which could happen anytime

[Jam4U @Jam4u_75]

Avacta Group PLC - Phase I study of AVA6000 advances to fourth cohort #AVCT @Avacta https://t.co/vTQzEtnSK1

#AVCT marching forward - this is looking very good indeed!

[Carlo Towl @Towlie1981]

Another hugely positive sign. Just goes to show that the settled narrative from some investors of 'there won't be a fourth cohort' was off the mark. Now to temper those expectations of a licensing deal prior to P1a data and let the SP settle #AVCT

[SR @SamJRobbo]

The mention of tolerability is a very important point not to be overlooked.

Safety & tolerability are two different sides of the same coin.

Tolerability is currently defined as: the degree to which overt adverse effects can be tolerated by the subject. Huge. #AVCT

[Oliver Smith @Smiffy_O]

#AVCT this 👇
🔥

[Romerley @romerley]

There have been so many high’s and lows with #AVCT but fourth dose escalation to treat cancer without side effects is very exciting 🤞

[Catrin Jones @Catjones71]

Bravo #AVCT 👏👏👏👏Well done AS & team

[Romerley @romerley]

@avacta This is fantastic news #AVCT

[Avacta @avacta]

Phase I clinical study of AVA6000 to advance to the fourth cohort. #AVCT https://t.co/T84DXuU5lh

[Vox Markets @VOXmarkets]

Avacta Group PLC - Phase I study of AVA6000 advances to fourth cohort #AVCT @Avacta https://t.co/UD9h3SECok #voxmarkets #investing #shares #RNS via @voxmarkets

[BBN @BigBiteNow]

#AVCT "escalates to the next dose of AVA6000 at 200mg/m2."

Wonderful news. The Avacta team must be delighted.

I stand by my previous comment. In my view, it's now mainly about establishing a fair valuation for AVA6000 and the future potential of the platform.

[Dom Von Posen @DomPosen]

#AVCT what a great news for trolls and shorters this morning 👍👍👍👍

[Pharmanaught @pharmanaught]

See this Instagram video by @aiylamakeup https://t.co/NWRK4KcKH1
#plouisebase #peachesmakeup #makeupjunkie #peachesandcream #glam #makeupideas #bridalmua #muafollowtrain #instamakeup #makeupartistsworldwide #morphe #muasupport #makeupbyme #fyp #softglam #partymakeup #asianmakeup

[Paul Summerfield @PaulSummerfield]

Just to clarify - Locum pharmacists are self employed contractors and cannot strike. They can choose to work or not work and part of this includes negotiating a fee for the work. This is misinformation that had been sent all patients who a registered with this GP surgery

[Share_Talk ™ @Share_Talk]

@avacta (AIM #AVCT) announces second dose escalation in Phase I clinical study of AVA6000 Pro-doxorubicin https://t.co/0EYJ4aqrvC via @share_talk

[Me @Skd884]

#AVCT

We are very pleased with the progress being made with ALS-6000-101 study and look forward to seeing more data as it emerges from the trial.”

https://t.co/KIizImo6bl

[PMH Capital @CapitalPmh]

#AVCT

More positive clinical trial data released from @avacta today. Saying the dosage level of its patented #AVA6000 pro-drug had been further increased.

Found out what this means for patients, doctors & investors here.

https://t.co/R2s9eQL2r7

[Proactive @proactive_x]

$AVCT Avacta Group jumps after positive drug study news https://t.co/nJpxVkp8gJ @avacta #AVCT #Katie_Proactive

[Drug Discovery World @DDWJournal]

@Avacta relocates HQ to London campus

https://t.co/xCSzuDJgVm

#Therapeutics